Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

[The new insulins].

Krzentowski G.

Rev Med Brux. 2005 Sep;26(4):S241-5. Review. French.

PMID:
16240869
2.

[The role of diabetes associations].

Krzentowski G.

Rev Med Liege. 2005 May-Jun;60(5-6):612-4. French.

3.

[Another look at the implications of the DCCT study].

Krzentowski G, Zhang L, Albert A, Lefèbvre PJ.

Ann Endocrinol (Paris). 2004 Oct;65(5):429-35. Review. French.

PMID:
15550885
4.

Factors predictive of nephropathy in DCCT Type 1 diabetic patients with good or poor metabolic control.

Zhang L, Krzentowski G, Albert A, Lefèbvre PJ.

Diabet Med. 2003 Jul;20(7):580-5.

PMID:
12823241
5.

The gene INPPL1, encoding the lipid phosphatase SHIP2, is a candidate for type 2 diabetes in rat and man.

Marion E, Kaisaki PJ, Pouillon V, Gueydan C, Levy JC, Bodson A, Krzentowski G, Daubresse JC, Mockel J, Behrends J, Servais G, Szpirer C, Kruys V, Gauguier D, Schurmans S.

Diabetes. 2002 Jul;51(7):2012-7.

6.

Relation between disease phenotype and HLA-DQ genotype in diabetic patients diagnosed in early adulthood.

Weets I, Siraux V, Daubresse JC, De Leeuw IH, Féry F, Keymeulen B, Krzentowski G, Letiexhe M, Mathieu C, Nobels F, Rottiers R, Scheen A, Van Gaal L, Schuit FC, Van der Auwera B, Rui M, De Pauw P, Kaufman L, Gorus FK; Belgian Diabetes Registry.

J Clin Endocrinol Metab. 2002 Jun;87(6):2597-605.

7.
8.

High frequency of persisting or increasing islet-specific autoantibody levels after diagnosis of type 1 diabetes presenting before 40 years of age. The Belgian Diabetes Registry.

Decochez K, Tits J, Coolens JL, Van Gaal L, Krzentowski G, Winnock F, Anckaert E, Weets I, Pipeleers DG, Gorus FK.

Diabetes Care. 2000 Jun;23(6):838-44.

9.

Usefulness of fluoxetine in obese non-insulin-dependent diabetics: a multicenter study.

Daubresse JC, Kolanowski J, Krzentowski G, Kutnowski M, Scheen A, Van Gaal L.

Obes Res. 1996 Jul;4(4):391-6.

10.

Fluoxetine therapy in obese diabetic and glucose intolerant patients.

Kutnowski M, Daubresse JC, Friedman H, Kolanowski J, Krzentowski G, Scheen A, Van Gaal L.

Int J Obes Relat Metab Disord. 1992 Dec;16 Suppl 4:S63-6.

PMID:
1338388
11.

[Transition from insulin U-40 to insulin U-100: the Belgian experience].

Van Gaal L, Krzentowski G, Rottiers R, Couturier E, Michel G, Lefèbvre PJ.

Diabete Metab. 1992 Jul-Aug;18(4):317-21. French. No abstract available.

PMID:
1459321
12.

Use of 13C substrates for metabolic studies in exercise: methodological considerations.

Lefèbvre PJ, Mosora F, Lacroix M, Pirnay F, Scheen A, Krzentowski G, Jandrain B, Gautier JF, Pallikarakis N, Riou JP, et al.

J Appl Physiol (1985). 1991 Nov;71(5):2059-61. No abstract available.

PMID:
1761508
13.

[Lack of benefit from the intermittent administration of insulin in treatment using subcutaneous perfusion pump in type 1 diabetes].

Lilet H, Krzentowski G, Bodson A, Scheen AJ, Lefebvre PJ.

Diabete Metab. 1991 May-Jun;17(3):363-72. French.

PMID:
1884881
14.

[Peroperative localization of insuloma using staged portal vein insulin assay. Apropos of a case].

el Nakadi B, Boudaka W, Rogowsky A, Krzentowski G, Bodson A.

Acta Chir Belg. 1991 Mar-Apr;91(2):77-80. French.

PMID:
2068888
15.

[Oral antidiabetic agents, yes but...].

Krzentowski G.

Rev Med Brux. 1988 Apr;9(3):144-7. French. No abstract available.

PMID:
3399759
16.

Utilization of oral sucrose load during exercise in humans. Effect of the alpha-glucosidase inhibitor acarbose.

Gerard J, Jandrain B, Pirnay F, Pallikarakis N, Krzentowski G, Lacroix M, Mosora F, Luyckx AS, Lefèbvre PJ.

Diabetes. 1986 Nov;35(11):1294-301.

PMID:
3530858
17.

Metabolic availability of carbohydrates ingested during, before, or after muscular exercise.

Lefèbvre PJ, Pirnay F, Pallikarakis N, Krzentowski G, Jandrain B, Mosora F, Lacroix M, Luyckx AS.

Diabetes Metab Rev. 1986;1(4):483-500. No abstract available.

PMID:
3720495
18.

Metabolic alterations after a two-hour nocturnal interruption of a continuous subcutaneous insulin infusion.

Scheen A, Castillo M, Jandrain B, Krzentowski G, Henrivaux P, Luyckx AS, Lefèbvre PJ.

Diabetes Care. 1984 Jul-Aug;7(4):338-42.

PMID:
6381007
19.

Metabolic availability of glucose ingested 3 h before prolonged exercise in humans.

Jandrain B, Krzentowski G, Pirnay F, Mosora F, Lacroix M, Luyckx A, Lefebvre P.

J Appl Physiol Respir Environ Exerc Physiol. 1984 May;56(5):1314-9.

PMID:
6427151
20.

Effect of physical training on utilization of a glucose load given orally during exercise.

Krzentowski G, Pirnay F, Luyckx AS, Lacroix M, Mosora F, Lefebvre PJ.

Am J Physiol. 1984 May;246(5 Pt 1):E412-7.

PMID:
6372520
21.

Availability of glucose given orally during exercise.

Krzentowski G, Jandrain B, Pirnay F, Mosora F, Lacroix M, Luyckx AS, Lefebvre PJ.

J Appl Physiol Respir Environ Exerc Physiol. 1984 Feb;56(2):315-20.

PMID:
6706743
22.

[Metabolic consequences of insulin deficiency].

Lefebvre PJ, Luyckx AS, Scheen AJ, Castillo M, Jandrain B, Krzentowski G.

Journ Annu Diabetol Hotel Dieu. 1984:163-74. Review. French. No abstract available.

PMID:
6152663
23.

Effect of physical training on the oxidation of an oral glucose load at rest: a naturally labeled 13C-glucose study.

Krzentowski G, Pirnay F, Luyckx AS, Lacroix M, Mosora F, Lefebvre PJ.

Diabete Metab. 1983 May-Jun;9(2):112-5.

PMID:
6352348
24.
25.

A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion: 2. Marked attenuation of the metabolic deterioration by somatostatin.

Scheen AJ, Krzentowski G, Castillo M, Lefèbvre PJ, Luyckx AS.

Diabetologia. 1983 May;24(5):319-25. No abstract available.

PMID:
6135635
26.

Fate of exogenous glucose during exercise of different intensities in humans.

Pirnay F, Crielaard JM, Pallikarakis N, Lacroix M, Mosora F, Krzentowski G, Luyckx AS, Lefebvre PJ.

J Appl Physiol Respir Environ Exerc Physiol. 1982 Dec;53(6):1620-4.

PMID:
7153158
27.

[Value of the artificial pancreas in the diagnosis of organic hypoglycemia].

Scheen A, Krzentowski G, Luyckx A, Lefebvre P.

Nouv Presse Med. 1982 Sep 25;11(37):2784-5. French. No abstract available.

PMID:
6292826
28.

Metabolic adaptations in post-exercise recovery.

Krzentowski G, Pirnay F, Luyckx AS, Pallikarakis N, Lacroix M, Mosora F, Lefèbvre PJ.

Clin Physiol. 1982 Aug;2(4):277-88.

PMID:
6751656
29.

[Glucose naturally marked with 13C for metabolic studies in man].

Lefebvre P, Mosora F, Lacroix M, Luyckx A, Pirnay F, Krzentowski G.

Bull Mem Acad R Med Belg. 1982;137(3):207-14. French. No abstract available.

PMID:
7116024
30.

Glucose utilization during exercise in normal and diabetic subjects. The role of insulin.

Krzentowski G, Pirnay F, Pallikarakis N, Luyckx AS, Lacroix M, Mosora F, Lefèbvre PJ.

Diabetes. 1981 Dec;30(12):983-9. No abstract available.

PMID:
7030833
31.

[Familial partial resistance to thyroid hormones. A report on one case (author's transl)].

Krzentowski G, Vandalem JL.

Ann Endocrinol (Paris). 1981 Dec;42(6):541-2. French.

PMID:
6808886
32.

Glucose oxidation in relation to the size of the oral glucose loading dose.

Mosora F, Lacroix M, Luyckx A, Pallikarakis N, Pirnay F, Krzentowski G, Lefèbvre P.

Metabolism. 1981 Dec;30(12):1143-9.

PMID:
6796801
33.

[Metabolic and hormonal adaptation of normal and diabetic subjects to muscular exercise].

Lefebvre P, Luyckx A, Krzentowski G, Pirnay F, Lacroix M, Mosora F, Pallikarakis N.

Rev Med Liege. 1980 Apr 15;35(8):250-4. French. No abstract available.

PMID:
7010488
34.

[Effect of benfluorex on the metabolic fate of an oral glucose load in obese subjects with reduced glucose tolerance (author's transl)].

Krzentowski G, Pallikarakis N, Lacroix M, Pirnay F, Mosora F, Luyckx A, Lefebvre P.

Therapie. 1979 Jul-Aug;34(4):445-55. French. No abstract available.

PMID:
531777
35.

[Glucose metabolism during muscular exercise in McArdle's disease].

Krzentowski G, Pallikarakis N, Pirnay F.

Acta Clin Belg. 1979;34(3):151-7. French. No abstract available.

PMID:
292291

Supplemental Content

Loading ...
Support Center